用橄榄叶安全地调节血压

高血压是最准确预测心血管疾病的一个指标，这个美国人的头号杀手之一。不幸的是，主流医学的高血压定义已经是太高。根据目前的医学定义，所谓的“阶段I高血压”是在140/90毫米汞柱。然而，大量科学文献表明，超过115/75毫米汞柱后，每增加20/10毫米汞柱，心血管疾病风险就增加一倍。如果“高血压（数值）”的定义被向下修正，以反映中度高血压，那么数以百万计的生命可能得以拯救。这句话的意思是，我们每个人需要采取一切必要措施，使血压得到控制，无论医生怎么说。

第一个问题是，远远过时的(上个世纪30年代初)高血压的医学定义，尽管研究人员已经发现，最佳的血压应该是115/75毫米汞柱左右。而且，医生很少治疗血压在医学“可接受的”读数140/90 毫米汞柱左右。

第二个问题是，即使当病人的血压一直在140/90毫米汞柱之上，传统的医生仍然固执地不愿意治疗它。通常情况下，读数超过160/90毫米汞柱时才开始治疗，这增加了不必要的死亡风险。

第三个问题是，大多数患者只能在每一天的一部分时间里控制血压在正常范围内。

高血压的危害是，它会逐渐破坏整个身体微妙的血管和器官，并伴有一系列病症：老年痴呆症、视网膜病变、肾功能衰竭，中风和心脏病发作。

目前，可用药物来治疗高血压带来了一系列不良的副作用：水肿，电解质紊乱。

橄榄苦甙，一种橄榄叶提取物，有利调节动脉阻力或硬化（血压高的核心机制）。科学实验发现，橄榄苦苷在仅仅8个星期内降低收缩压平均11.5毫米汞柱，舒张压降低4.8毫米汞柱。

参考文献：

1. Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study. J Am Coll Cardiol. 2011 Nov 29;58(23):2396-403.

2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003 May 21;289(1):2560-75.

3. Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ. 2011 Nov 21.

4. Susalit E, Agus N, Effendi I, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with captopril. Phytomedicine. 2011 Feb 15;18(4):251-8.

5. Jänicke C, Grünwald J, Brendler T. Handbuch Phytotherapie. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft; 2003.

6. Cherif S, Rahal N, Haouala M, et al. A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension. J Pharm Belg. 1996 Mar-Apr;51(2):69-71.

7. Bennani-Kabchi N, Fdhil H, Cherrah Y, et al. Effects of Olea europaea var. oleaster leaves in hypercholesterolemic insulin-resistant sand rats. Therapie. 1999 Nov-Dec;54(6):717-23.

8. Bennani-Kabchi N, Fdhil H, Cherrah Y, El Bouayadi F, Kehel L, Marquie G. Therapeutic effect of Olea europea var. oleaster leaves on carbohydrate and lipid metabolism in obese and prediabetic sand rats (Psammomys obesus). Ann Pharm Fr. 2000 Jul;58(4):271-7.

9. Petkov V, Manolov P. Pharmacological analysis of the iridoid oleuropein. Arzneiforschung. 1972 Sep;22(9):1476-86.

10. Available at: http://www.medicinenet.com/high_blood_pressure/page4.htm. Accessed November 19, 2011.

11. Perrinjaquet-Moccetti1 T, Busjahn A, Schmidlin C, Schmidt A, Brad B, Aydogan C. Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother. Res.2008;22:1239-42.

12. Benolea® EFLA 943. Unpublished study. October 11, 2011.

13. Scheffler A, Rauwald HW, Kampa B, Mann U, Mohr FW, Dhein S. Olea europaea leaf extract exerts L-type Ca2+ channel antagonistic effects. J Ethnopharmacol. 2008 Nov 22;120(2):233-40.

14. Gilani AH, Khan A, Shah AJ, Connor J, Jabeen Q. Blood pressure lowering effect of olive is mediated through calcium channel blockade. Int J Food Sci Nutr. 2005 Dec;56(8):613-20.

15. Pedrinelli R, Dell’Omo G, Mariani M. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension. J Hum Hypertens. 2001 Jul;15(7):455.

16. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik R. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 1996 Apr 20;347(9008):1061.

17. Textor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol. 1997 Jan;17(1):67-76.

18. Thomas MC. Diuretics, ACE inhibitors and NSAIDs--the triple whammy. Medical J Aust. 2000 Feb 21;172(4):184-5.

19. Textor SC, Bravo EL, Fouad FM, et al. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med. 1982 Nov;73(5):719-25.

20. Cruz CS, Cruz AA, Marcilio de Souza CA. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone. Nephrol Dial Transplant. 2003 Sep;18(9):1814-9.

21. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995 Aug 23-30;274(8):620-5.

22. Nelson M. Drug treatment of elevated blood pressure. Austr Prescriber. 2010;33:108-12.

23. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 Jan 27;119(3):e21-e181.

24. Malik N, Bradford JM. Recovery and stability of oleuropein and other phenolic compounds during extraction and processing of olive (Olea europaea L.) leaves. J Food Agric Environ. 2008 Apr 1;6(2):8-13.

25. Visioli F, Bellosta S, Galli C. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sciences. 1998 Jan 2;62(6):541-6.

26. Khayyal MT, El-Ghazaly MA, Abdall DM, Okpanyi SN, Kreuter MH. Blood pressure lowering effect of an olive leaf extract (Olea europaea) in L-NAME induced hypertension in rats. Arzneimittelforschung. 2002;52(11):797-802.

27. Perrinjaquet-Moccetti1 T, Busjahn A, Schmidlin C, Schmidt A, Brad B, Aydogan C. Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother. Res.2008;22:1239-42.

28. Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomized controlled trials. Lancet Oncol. 2010 Jul;11(7):627-36.

29. Schmieder RE. End organ damage in hypertension. Dtsch Arztebl Int. 2010 Dec;107(49):866-73.

30. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.

31. Hyman DJ, Pavlik VN. Poor hypertension control: Let’s stop blaming the patients. Cleve Clin J Med. 2002 Oct;69(10):793-9.